We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

19 May 2026 - 22 May 2026
17 Jun 2026 - 19 Jun 2026
05 Oct 2026 - 06 Oct 2026

Breath Test Aids Diagnosis of Delayed Gastric Emptying

By HospiMedica International staff writers
Posted on 13 Apr 2015
A new noninvasive test for delayed gastric emptying, also known as gastroparesis, can be performed in a general clinical setting and does not require radioactive material.

The Gastric Emptying Breath Test (GEBT) is designed to show how fast the stomach empties solids by measuring carbon dioxide (CO2) in a patient’s breath. More...
Patients have baseline breath tests at the beginning of the four-hour test; they then eat a test meal that includes a scrambled egg-mix and Spirulina platensis, a protein enriched with carbon-13, a naturally existing non-radioactive form of carbon-12 which can be measured in breath samples. Both carbon-12 and a very small amount of carbon-13 are normally found in exhaled CO2.

By adding carbon-13 to the test meal, the GEBT can determine how fast the stomach empties the meal by measuring the ratio of carbon-13 to carbon-12 collected in breath samples at multiple time points after the meal is consumed. Clinical data from 115 participants who underwent a gastric emptying test with both the GEBT and gastric scintigraphy (the standard of care for measuring gastric emptying) showed a 73%–97% match between the test results, depending when measured during the test. The GEBT is manufactured by Advanced Breath Diagnostics (Brentwood, TN, USA), and has been approved by the US Food and Drug Administration (FDA; Silver Spring, MD, USA).

“The GEBT is another option for aiding in the diagnosis of gastroparesis,” said Alberto Gutierrez, PhD, director of the Office of In Vitro Diagnostics and Radiological Health in the FDA’s Center for Devices and Radiological Health (CADR). “It can be performed in any clinical setting since it does not require the health care professionals administering the test to undergo special training or to take special precautions related to radiation emitting compounds.”

Gastroparesis is a disorder that slows or stops the movement of food from the stomach to the small intestine due to damage to the vagus nerve, causing improper contraction of the muscles of the stomach and small intestine. It is often the result of intestinal surgery, neurological diseases such as Parkinson’s disease and multiple sclerosis (MS), or high blood glucose levels due to diabetes. If left untreated, gastroparesis can lead to severe dehydration due to persistent vomiting, difficulty managing blood sugar levels in diabetics, and malnutrition due to poor absorption of nutrients or low caloric intake.

Related Links:

US Food and Drug Administration



New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
12-Channel ECG
CM1200B
New
Tourniquet System
heidi– mein Tourniquet
New
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.